Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes

NCT04974489 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1153

Last updated 2022-11-08

Study results available
· View outcomes & findings →

Summary

Tobacco use is the leading preventable cause of cancer and cancer deaths in the US. While most (69%) smokers want to quit, only 6% succeed in doing so each year. For many smokers, the addictiveness of nicotine makes quitting very difficult. To reduce cigarette smoking and resulting harms, FDA has announced a comprehensive approach to tobacco and nicotine regulation that includes moving toward a very low nicotine content (VLNC) standard for cigarettes. Greatly reduced nicotine levels would facilitate smoking cessation. However, the maximal success of the policy may require public understanding that, although these new cigarettes are less addictive, their high toxicity and carcinogenicity are unchanged. Yet, nearly half of adult smokers incorrectly think smoking VLNC cigarettes is less harmful than smoking current cigarettes (the VLNC misperception). Additionally, 24% of smokers said they would be less likely to quit if a VLNC regulation is enacted. Thus, the VLNC misperception may partially undermine a nicotine reduction policy. Although communication research suggests it is challenging to change people's incorrect understanding, new communication techniques may help reduce the VLNC misperception. In this randomized trial we will examine whether messages about the harm of VLNC cigarettes can reduce the VLNC misperception and increase intention to quit in a nicotine reduction scenario.

Conditions

  • Tobacco Use, Cigarette Use

Interventions

BEHAVIORAL

Emotion-based messages about the harm of VLNC

Participants in this arm will receive 3 emotion-based messages about the harm of VLNC during the survey data collection.

BEHAVIORAL

Continued-harm-framed messages about the harm of VLNC

Participants in this arm will receive 3 continued-harm-framed messages about the harm of VLNC during the survey data collection.

BEHAVIORAL

Myth-refuting messages about the harm of VLNC

Participants in this arm will receive 3 myth-refuting messages messages about the harm of VLNC during the survey data collection.

BEHAVIORAL

Control messages about littering

Participants in this arm will receive 3 control messages about littering during the survey data collection.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • M. Justin Byron, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2021-08-03
Completion
2021-08-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04974489 on ClinicalTrials.gov